Browsing by Author Economopoulos, T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 20 to 36 of 36 < previous 
TitleAuthor(s)Issue date???itemlist.???
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.24-Nov-2015-
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papakostas, P.; Dafni, U.; Makatsoris, T.; Karina, M.; Kalogera-Fountzila, A.; Maniadakis, N.; Aravantinos, G.; Syrigos, K.; Bamias, A.; Christodoulou, C.; Economopoulos, T.; Kalofonos, H.; Nikolaou, A.; Angouridakis, N.; Stathopoulos, G.; Bafaloukos, D.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck - A Hellenic cooperative oncology group phase II studyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II StudyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsPentheroudakis, G.; Fountzilas, G.; Kalofonos, H. P.; Golfinopoulos, V.; Aravantinos, G.; Bafaloukos, D.; Papakostas, P.; Pectasides, D.; Christodoulou, C.; Syrigos, K.; Economopoulos, T.; Pavlidis, N.24-Nov-2015-
A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphomaXiros, N.; Economopoulos, T.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Raptis, S.24-Nov-2015-
Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group)Economopoulos, T.; Fountzilas, G.; Kostourou, A.; Daniilidis, J.; Pavlidis, N.; Andreopoulou, H.; Nicolaou, A.; Papageorgiou, E.; Mellou, S.; Dervenoulas, J.; Stathakis, N.24-Nov-2015-
Primary extranodal non-Hodgkin's lymphoma of the head and neckEconomopoulos, T.; Asprou, N.; Stathakis, N.; Fountzilas, G.; Pavlidis, N.; Papaspyrou, S.; Dervenoulas, J.; Belia, M.; Papageorgiou, E.; Theoharis, D.; et al.,24-Nov-2015-
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)Papaxoinis, G.; Papageorgiou, S.; Rontogianni, D.; Kaloutsi, V.; Fountzilas, G.; Pavlidis, N.; Dimopoulos, M.; Tsatalas, C.; Xiros, N.; Economopoulos, T.24-Nov-2015-
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyPsyrri, A.; Kalogeras, K. T.; Kronenwett, R.; Wirtz, R. M.; Batistatou, A.; Bournakis, E.; Timotheadou, E.; Gogas, H.; Aravantinos, G.; Christodoulou, C.; Makatsoris, T.; Linardou, H.; Pectasides, D.; Pavlidis, N.; Economopoulos, T.; Fountzilas, G.24-Nov-2015-
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group studyFountzilas, G.; Vasilaros, S.; Koukouras, D.; Malamos, N.; Pectasides, D.; Adamou, A.; Nenopoulou, E.; Kiriakou, K.; Zouvani, I.; Katsohis, K.; Kappas, A.; Skopa, C.; Semoglou, C.; Fahantidis, E.; Konstantaras, C.; Vasilaki, E.; Economopoulos, T.; Bacoyiannis, H.; Bafaloukos, D.; Razi, E.; Polichronis, A.; Androulakis, G.; Papaioannou, T.; Pavlidis, N.; Kosmidis, P.; et al.,24-Nov-2015-
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group StudyKalofonos, H. P.; Bamias, A.; Koutras, A.; Papakostas, P.; Basdanis, G.; Samantas, E.; Karina, M.; Misailidou, D.; Pisanidis, N.; Pentheroudakis, G.; Economopoulos, T.; Papadimitriou, C.; Skarlos, D. V.; Pectasides, D.; Stavropoulos, M.; Bafaloukos, D.; Kardamakis, D.; Karanikiotis, C.; Vourli, G.; Fountzilas, G.24-Nov-2015-
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group studyPapadimitriou, C. A.; Papakostas, P.; Karina, M.; Malettou, L.; Dimopoulos, M. A.; Pentheroudakis, G.; Samantas, E.; Bamias, A.; Miliaras, D.; Basdanis, G.; Xiros, N.; Klouvas, G.; Bafaloukos, D.; Kafiri, G.; Papaspirou, I.; Pectasides, D.; Karanikiotis, C.; Economopoulos, T.; Efstratiou, I.; Korantzis, I.; Pisanidis, N.; Makatsoris, T.; Matsiakou, F.; Aravantinos, G.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphomaEconomopoulos, T.; Fountzilas, G.; Pavlidis, N.; Kalantzis, D.; Papageorgiou, E.; Christodoulou, C.; Hamilos, G.; Nicolaides, C.; Dimopoulos, M.24-Nov-2015-
Second malignancies following treatment for Hodgkin's disease: a Greek experienceEconomopoulos, T.; Stathakis, N.; Alexopoulos, C.; Pavlidis, N.; Constantinidou, M.; Briassoulis, E.; Papageorgiou, E.; Dervenoulas, J.; Pappa, V.; Vaslamatzis, M.; et al.,24-Nov-2015-
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survivalKostadima, L.; Pentheroudakis, G.; Fountzilas, G.; Dimopoulos, M.; Pectasides, D.; Gogas, H.; Stropp, U.; Christodoulou, C.; Samantas, E.; Wirtz, R.; Hennig, G.; Bafaloukos, D.; Arapantoni, P.; Kalofonos, H.; Papakostas, P.; Economopoulos, T.; Bamias, A.; Pavlidis, N.24-Nov-2015-
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOPEconomopoulos, T.; Dimopoulos, M. A.; Mellou, S.; Pavlidis, N.; Samantas, E.; Nicolaides, C.; Tsatalas, C.; Papadopoulos, A.; Papageogriou, E.; Papasavvas, P.; Fountzilas, G.24-Nov-2015-